BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 17, 2003
View Archived Issues
Primal Publishes GPCR Data, Comes Out Of 'Stealth Mode'
Read More
NimbleGen Completes $12.5M Round For Microarray Business
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More
Genzyme Hits EPS Estimates, Reports Delay In Renagel Trial
Genzyme General's first-quarter revenue blossomed nicely and the company hit its earnings-per-share estimates, but the revelation of a data delay from a Renagel trial dropped the company's stock Wednesday. (BioWorld Today)
Read More
GlycoFi Scientists Devise Genetic Combinatorial Library To Develop Humanized Glycosylation Displays
Read More